Menu

Black Diamond Therapeutics, Inc. BDTX

Full chart Compare
Set alert

Price alert · BDTX

All alert types
1.66 USD -0.24 (-12.63%)

At closeNov 5, 2026, 6:39 PM EST

1.68 +0.02 +0.92%

After hours · Nov 5, 6:39 PM ET

1.65 Day range 1.90
1.61 52-week range 4.87
YTD
-31.69%
1 year
-57.11%

Revenue & Expenses

Other Income → Gross Profit & Other Income: $2.50MGross Profit & Other Income → Net Income: $22.37MGross Profit & Other Income → Selling, General & Admin: $16.57MGross Profit & Other Income → Research & Development: $33.56MOther Operating Income → Gross Profit & Other Income: $325.00KGross Profit → Gross Profit & Other Income: $69.67MRevenue → Gross Profit: $69.67MRevenue → Cost of Revenue: $325.00KOther Income$2.50MOther Operating Income$325.00KGross Profit$69.67MCost of Revenue$325.00KGross Profit & Other Income$72.50MNet Income$22.37MSelling, General & Admin$16.57MResearch & Development$33.56MRevenue$70.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BDTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
70.00M0000
70.00M0000
12.52M-78.78M-86.46M-92.83M-126.87M
22.37M-69.68M-82.44M-91.17M-125.60M
0.39-1.27-1.88-2.52-3.47
BDTX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
21.82M37.26M57.04M35.48M67.02M
143.01M122.64M158.57M156.25M247.68M
30.80M39.35M41.83M40.56M51.78M
15.07M18.78M22.18M25.30M28.14M
112.21M83.28M116.74M115.69M195.90M
BDTX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
29.61M-62.30M-66.72M-85.08M-100.15M
-44.91M16.97M16.35M53.37M130.61M
-146.00K25.55M71.93M177.00K729.00K
27.00K94.00K62.00K-183.00K-2.71M
-15.44M-19.79M21.56M-31.54M31.19M